Effect of a Third COVID-19 Booster Among Health Care Workers
Sponsored by Hong Kong Sanatorium & Hospital
About this trial
Last updated 3 years ago
Study ID
Third COVID-19 booster
Status
Not yet recruiting
Type
Observational
Placebo
No
Accepting
18+ Years
All
Trial Timing
Ended 2 years ago
What is this trial about?
A new wave of COVID-19 infections, mainly caused by the Omicron/ Delta variant, has been
sweeping the globe since the start of 2022. In response, the administration of a third dose
of COVID-19 vaccine was considered to address potential waning immunity over time and reduced
effectiveness against the Omicron/ Delta variant. The pandemic also resulted in many
infections among health care workers (HCWs) and their households. In this study, a
retrospective analysis would perform on risk of COVID-19 infection and their outcome in
relation to their COVID-19 vaccination history by using the data repository from one of the
Hong Kong private hospitals.
HCWs were required to submit a standardized online self-declaration form for report of 1)
demographic of the HCWs, 2) symptoms related history and 3) COVID-19 exposure history once
they were COVID-19 confirmed by rapid antigen test against COVID-19 and/or polymerase chain
reaction (PCR) test for COVID-19. Subsequent follow up such as contact tracing, COVID-19 PCR
testing results of these HCWs and status of return to work were captured by the infection
control team in a systematic manner.
What are the participation requirements?
Inclusion Criteria
- All full time staff members of the private hospital
Exclusion Criteria
- History of COVID-19 before 2022